Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model

10.1007/s11307-009-0213-4

Saved in:

Bibliographic Details
Main Authors:	Ong, L.-C., Song, I.-C., Jin, Y., Kee, I.H.C., Siew, E., Yu, S., Thng, C.-H., Huynh, H., Chow, P.K.H.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Subjects:	18F-FDG-PET Bevacizumab Hepatocellular carcinoma Micro-CT Micro-PET Orthotopic xenograft model Rapamycin Tumor vasculature
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110050
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-110050
record_format	dspace
spelling	sg-nus-scholar.10635-1100502024-11-08T18:17:32Z Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model Ong, L.-C. Song, I.-C. Jin, Y. Kee, I.H.C. Siew, E. Yu, S. Thng, C.-H. Huynh, H. Chow, P.K.H. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE 18F-FDG-PET Bevacizumab Hepatocellular carcinoma Micro-CT Micro-PET Orthotopic xenograft model Rapamycin Tumor vasculature 10.1007/s11307-009-0213-4 Molecular Imaging and Biology 11 5 334-342 CPIMF 2014-11-26T08:27:59Z 2014-11-26T08:27:59Z 2009 Article Ong, L.-C., Song, I.-C., Jin, Y., Kee, I.H.C., Siew, E., Yu, S., Thng, C.-H., Huynh, H., Chow, P.K.H. (2009). Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model. Molecular Imaging and Biology 11 (5) : 334-342. ScholarBank@NUS Repository. https://doi.org/10.1007/s11307-009-0213-4 15361632 http://scholarbank.nus.edu.sg/handle/10635/110050 000268584000007 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	18F-FDG-PET Bevacizumab Hepatocellular carcinoma Micro-CT Micro-PET Orthotopic xenograft model Rapamycin Tumor vasculature
spellingShingle	18F-FDG-PET Bevacizumab Hepatocellular carcinoma Micro-CT Micro-PET Orthotopic xenograft model Rapamycin Tumor vasculature Ong, L.-C. Song, I.-C. Jin, Y. Kee, I.H.C. Siew, E. Yu, S. Thng, C.-H. Huynh, H. Chow, P.K.H. Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
description	10.1007/s11307-009-0213-4
author2	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Ong, L.-C. Song, I.-C. Jin, Y. Kee, I.H.C. Siew, E. Yu, S. Thng, C.-H. Huynh, H. Chow, P.K.H.
format	Article
author	Ong, L.-C. Song, I.-C. Jin, Y. Kee, I.H.C. Siew, E. Yu, S. Thng, C.-H. Huynh, H. Chow, P.K.H.
author_sort	Ong, L.-C.
title	Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
title_short	Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
title_full	Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
title_fullStr	Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
title_full_unstemmed	Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
title_sort	effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/110050
_version_	1821201689339756544

Effective inhibition of xenografts of hepatocellular carcinoma (hepg2) by rapamycin and bevacizumab in an intrahepatic model

Similar Items